Petros Pharmaceuticals
OTC: PTPINew York, US · Founded 2020 · Delaware corporation
Petros Pharmaceuticals is a bio-pharmaceutical company working to convert prescription drugs into over-the-counter self-care treatments, allowing consumers access without a physician visit or prescription. It operates in the emerging self-care pharmaceutical market.
Founders & leadership
MA
Mitchell ArnoldinVice President of Finance and Principal Accounting Officer
AG
Andrew GesekPresident, Timm Medical
FB
Fady BoctorinPresident, Chief Commercial Officer
JD
John D. ShulmanNamed on SEC filing
WR
Wayne R. WalkerNamed on SEC filing
GB
Gregory BradleyNamed on SEC filing
JN
Joshua N. SilvermanNamed on SEC filing
BT
Bruce T. BernsteinNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$35.7M disclosed across 3 of 4 rounds · 2021–2023
▶$30MraisedJul 2023 · 15 investors · PharmaceuticalsRule 506(b)
▶$30MraisedJul 2023 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John D. ShulmanDirector
- Mitchell ArnoldExecutive Officer
- Wayne R. WalkerDirector
- Fady BoctorExecutive Officer
- Gregory BradleyDirector
- Joshua N. SilvermanDirector
- Bruce T. BernsteinDirector
- Offering amount
- $30M
- Amount sold
- $30M
- Sales commissions
- $1.2M
- Placement agents
- Katalyst Securities LLC
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.2MraisedJan 2022 · 12 investors · PharmaceuticalsRule 506(b)
▶$2.2MraisedJan 2022 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mitchell ArnoldExecutive Officer
- Gregory BradleyDirector
- Joshua N. SilvermanDirector
- Fady BoctorExecutive Officer
- John D. ShulmanDirector
- Andrew GesekExecutive Officer
- Bruce T. BernsteinDirector
- Wayne R. WalkerDirector
- Offering amount
- $8.3M
- Amount sold
- $2.2M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$3.5MraisedDec 2021 · 12 investors · PharmaceuticalsRule 506(b)
▶$3.5MraisedDec 2021 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Andrew GesekExecutive Officer
- Wayne R. WalkerDirector
- Mitchell ArnoldExecutive Officer
- Fady BoctorExecutive Officer
- Bruce T. BernsteinDirector
- John D. ShulmanDirector
- Gregory BradleyDirector
- Joshua N. SilvermanDirector
- Offering amount
- $12.8M
- Amount sold
- $3.5M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$5.9MofferedOct 2021 · 10 investors · PharmaceuticalsRule 506(b)
▶$5.9MofferedOct 2021 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John D. ShulmanDirector
- Wayne R. WalkerDirector
- Gregory BradleyDirector
- Mitchell ArnoldExecutive Officer
- Andrew GesekExecutive Officer
- Fady BoctorExecutive Officer
- Joshua N. SilvermanDirector
- Bruce T. BernsteinDirector
- Offering amount
- $5.9M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlap
Robinhood13 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
StockTwits13 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Simply Wall St12 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Perplexity12 shared keywordsAn AI-powered answer engine providing accurate, trusted, and real-time answers to questions.
Itiger12 shared keywordsTiger Brokers is a global online brokerage that lets clients trade equities, futures, options, and funds across U.S., Hong Kong, Singapore, and Australian markets through its Tiger Trade mobile app. Beyond brokerage, it offers ESOP management, investment banking, wealth management, and investor education, and is listed on NASDAQ under the ticker TIGR.
TradingView11 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
TipRanks11 shared keywordsFinancial analysis and stock research platform.
Companies competing with Petros Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Petros Pharmaceuticals do?
- Petros Pharmaceuticals is a bio-pharmaceutical company working to convert prescription drugs into over-the-counter self-care treatments, allowing consumers access without a physician visit or prescription. It operates in the emerging self-care pharmaceutical market.
- How much funding has Petros Pharmaceuticals raised?
- Petros Pharmaceuticals has disclosed $35.7M raised across 3 of its 4 known rounds.
- Where is Petros Pharmaceuticals headquartered?
- Petros Pharmaceuticals is headquartered in New York, US.